Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Epidemiological studies in the HTA evaluation process].

T Behrens1, W Ahrens

  • 1Bremer Institut für Präventionsforschung und Sozialmedizin. behrens@bips.uni-bremen.de

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|February 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

VOYAGER: an international consortium investigating the role of human papilloma virus and genetics in oral and oropharyngeal cancer risk and survival.

medRxiv : the preprint server for health sciences·2025
Same author

Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites.

medRxiv : the preprint server for health sciences·2024
Same author

Cross-sectional and longitudinal associations between sleep duration, sleep quality, and bone stiffness in European children and adolescents.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

A within-sibling pair analysis of lifestyle behaviours and BMI z-score in the multi-centre I.Family study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
Same author

Predictors of oropharyngeal cancer survival in Europe.

Oral oncology·2018
Same author

Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.

PloS one·2018
Same journal

[Applying the German demand planning guideline to maternity care provision: regional and socioeconomic disparities].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Medical aids for children and adolescents following the legislative change-a status report].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Doping: caught between fraud, health protection, and responsibility].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Aging with intellectual and developmental disabilities or severe multiple disabilities-health, participation, and care in later life].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Sexual self-determination and disability: 10 years of the ReWiKs project-dynamics and findings].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same journal

[Legal and societal aspects of doping in sport].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
See all related articles

Epidemiological studies enhance drug benefit evaluations in health technology assessment (HTA). Pharmaco-epidemiology offers real-world effectiveness and safety data, improving targeted therapies.

Area of Science:

  • Health Technology Assessment
  • Pharmaco-epidemiology
  • Observational Research

Background:

  • Clinical trials often lack diverse patient populations.
  • Real-world data from epidemiological studies are crucial for comprehensive drug evaluation.
  • Understanding drug effectiveness and safety in broader populations is essential.

Purpose of the Study:

  • To highlight the importance of epidemiological studies in Health Technology Assessment (HTA).
  • To discuss the utility of pharmaco-epidemiological databases for assessing drug effectiveness and safety.
  • To explore challenges and propose solutions for integrating observational data into HTA.

Main Methods:

  • Review of pharmaco-epidemiological asthma studies.
  • Analysis of potential biases in observational data.

Related Experiment Videos

  • Discussion of methods for integrating real-world evidence into HTA.

    • Main Results:

    • Pharmaco-epidemiological databases provide insights into drug effectiveness in underrepresented groups.
    • These databases aid in evaluating drug safety across diverse socio-demographic factors.
    • Challenges in interpreting observational data due to bias were identified.

    Conclusions:

    • Epidemiological data are vital for a holistic view of drug benefits in HTA.
    • Standardized methods for epidemiological data analysis, like pooled analysis, are needed.
    • Integrating real-world evidence can lead to more optimal and targeted pharmacological therapies.